Document is current
Any future updates will be listed below
-
Authors
Cui, Yumeng
Wu, Xiaojie
Jin, Jie
Man, Weiling
Li, Jie
Li, Xiang
Li, Yanghua
Yao, He
Zhong, Rongbin
Chen, Shiyun
Wu, Jiahui
Zhu, Tianhao
Lin, Yanli
Xu, Junjie
Wang, Youliang
-
Funding
Funding for this research was provided by:
National Key Research and Development Program of China (2022YFC3600100, 2019YFA0903802)
- License Information
-
More Information
Article History
Received: 19 June 2023
Accepted: 24 October 2023
First Online: 6 November 2023
Declarations
:
: Studies using human tissues were authorized by the Ethics Committee of Chinese PLA General Hospital and the Ethics Committee of Beijing Institute of Biotechnology (Approval number: AF/SC-08/02.216), and performed in accordance with the principles of Declaration of Helsinki. The animal study was approved by the Animal Ethic Review Committees of Beijing Institute of Biotechnology (Approval number: IACUC-DXZW-2021-021). All animal experiments were strictly implemented in compliance with the NIH Guide for the Care and Use of Laboratory Animals.
: All authors give consent for the publication of manuscript in Molecular Cancer.
: The authors declare no competing interests.
